Louise Frederika Kooij
Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 70,20059,153 held (−54%) | $29.96 | $2.1M | -28.0% |
| Jul 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 31,88527,268 held (−54%) | $31.05 | $990K | -30.5% |
| Jul 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 2,91524,353 held (−11%) | $31.71 | $92K | -32.0% |
| Jun 24SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 39,70024,653 held (−62%) | $30.20 | $1.2M | -28.6% |
| Jun 24SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 30024,353 held (−1%) | $30.73 | $9K | -29.8% |
| May 27SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 65,00024,353 held (−73%) | $35.69 | $2.3M | -39.5% |
| Jan 29SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 39,81624,353 held (−62%) | $32.62 | $1.3M | -33.9% |
| Jan 29SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 32,61224,353 held (−57%) | $31.80 | $1.0M | -32.2% |
| Jan 27SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 25,40537,120 held (−41%) | $33.44 | $850K | -35.5% |
| Jan 27SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 12,76724,353 held (−34%) | $34.37 | $439K | -37.2% |
| Jan 27SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 34,09124,662 held (−58%) | $32.77 | $1.1M | -34.2% |
| Jan 27SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 30924,353 held (−1%) | $33.45 | $10K | -35.5% |
| Jan 7SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 2,64712,353 held (−18%) | $33.25 | $88K | -35.1% |
| Dec 29SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 75,11715,000 held (−83%) | $36.21 | $2.7M | -40.4% |
| Dec 29SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 26,01115,000 held (−63%) | $35.68 | $928K | -39.5% |
| Dec 29SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 43,87215,000 held (−75%) | $35.30 | $1.5M | -38.9% |
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $2.1M of NAMS at $29.96 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $990K of NAMS at $31.05 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $92K of NAMS at $31.71 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $1.2M of NAMS at $30.20 — cuts the stake by 62%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $9K of NAMS at $30.73 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Louise Frederika Kooij sold $2.3M of NAMS at $35.69 — cuts the stake by 73%; pre-scheduled 10b5-1 plan sale.